Our commitment to Environmental, Social, and Governance (ESG) excellence is at the heart of everything we do.
At Zutron Pharmaceuticals, we are committed to building a healthier future—not only through our products, but through the way we operate. Our ESG practices guide our decisions and reflect our responsibility to our communities, our environment, and our stakeholders.
We are steadily adopting renewable energy solutions to reduce our dependence on fossil fuels and lower our operational carbon footprint.
We continue to implement digital processes across our operations to minimize waste and conserve natural resources.
We manage waste responsibly to protect the environment and ensure safe operations.
We continuously improve efficiency to reduce our ecological footprint.
We are committed to fostering a safe, supportive, and empowering work environment that prioritizes the physical well-being of all employees across our operations.
We implement regular safety training, provide appropriate personal protective equipment (PPE), and ensure full compliance with workplace health and safety regulations. During periods of increased health risk, such as flu seasons or pandemics, we proactively supply employees with face masks, sanitizers, and other essential protective materials.
We also prioritize the safety of our logistics and delivery personnel, enforcing safe transportation practices including the use of seat belts, protective helmets, and adherence to road safety protocols during the distribution of pharmaceutical products.
Through these measures, we reinforce our ESG commitment to protecting our people, minimizing occupational risks, and maintaining a culture of safety across all levels of the organization.
We believe in giving back to the communities we serve by supporting initiatives that improve access to healthcare and promote public health awareness.
Through our partnership with the Ntuune Pogyua Foundation, we donated antimalarial and antibiotic medications to support senior citizens in the Northern Region of Ghana, and provided laboratory supplies and consumables to strengthen diagnostic services and healthcare delivery at the community level.
In addition, we supported the International Infection Prevention Week organized by the 37 Military Hospital, serving as a headline sponsor for the week-long public health program. The initiative engaged over 100 healthcare professionals, promoted best practices in infection prevention and control, and concluded with an award ceremony recognizing medical wards that demonstrated strong adherence to infection prevention standards.
These engagements reflect our commitment to community well-being, healthcare education, and sustainable health outcomes.
We maintain transparent operations guided by regulatory standards and ethical business practices.
Anti-corruption policies
Regulatory compliance across all product lines
Strict vendor and procurement due diligence
We safeguard sensitive data through responsible digital practices.
Secure digital storage
Controlled access to information systems
Zutron Pharmaceuticals has implemented a Quality Management System aligned with the principles of ISO 9001:2015 and Good Distribution Practice (GDP) to support effective governance, risk management, and operational control.
Although formal ISO 9001:2015 certification is currently in progress, our documented policies, procedures, and controls are actively applied across the business, as outlined in our approved Quality Management Manual.
As part of our governance framework, we adhere to key ISO and GDP principles, including:
The scope of our Quality Management System covers the procurement, warehousing, distribution, installation, and servicing of pharmaceuticals, medical devices, and laboratory equipment, including Importer and Exporter of Record (IOR/EOR) services.
Through this ISO-aligned and GDP-compliant governance approach, Zutron Pharmaceuticals reinforces transparency, strengthens risk control, and supports long-term sustainability while progressing toward full ISO 9001:2015 certification.